Collegium Pharmaceutical Inc
COLL
Market Cap$1.19B
Close$
$48.84
37.8% upside
Current Fair Value
37.8% upsideUndervalued by 37.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.19 Billion |
|---|---|
| Enterprise Value | $1.55 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $1.15 |
| Beta | 0.59 |
| Outstanding Shares | 32,705,747 |
| Avg 30 Day Volume | 502,080 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 24.72 |
|---|---|
| PEG | -4.55 |
| Price to Sales | 2.09 |
| Price to Book Ratio | 7.09 |
| Enterprise Value to Revenue | 2.73 |
| Enterprise Value to EBIT | 9.26 |
| Enterprise Value to Net Income | 32 |
| Total Debt to Enterprise | 0.43 |
| Debt to Equity | 3.41 |
Revenue Sources
No data
ESG Score
No data
About Collegium Pharmaceutical Inc
CEO: Joseph Ciaffoni